Toggle navigation
Data Resources
Computing Analysis
Data Network
Standards
OpenLB
Open Library of Bioscience
Search
Advanced Search
Journal
Select Journal
Publication Year
1 year
3 years
5 years
10 years
From
2021 - 2032
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
To
2021 - 2032
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
Publication Type
Case Reports
Comment
Comparative Study
Editorial
Letter
Journal Article
Review
Preprint
Associated Data
YES
Found 369 results
Sort by:
Best match
Best match
Most recent
Publication date
Filters:
emerging antibacterials
Antibacterials: are the new entries enough to deal with the emerging resistance problems?
Christine T Barrett, John F Barrett
Curr Opin Biotechnol
. Dec, 2003.14(6):621-6 Print
Source:PubMed
PMID:
14662392
doi:10.1016/j.copbio.2003.10.003
Phages and phage-borne enzymes as new antibacterial agents.
Shawna McCallin, Zuzanna Drulis-Kawa, Tristan Ferry, Jean-Paul Pirnay, Ran Nir-Paz, ESGNTA – ESCMID study group for non-traditional antibacterials
Clin Microbiol Infect
. Oct 20, 2023.: Print-Electronic
Source:PubMed
PMID:
37866680
doi:10.1016/j.cmi.2023.10.018
Current challenges in the discovery of novel antibacterials from microbial natural products.
Olga Genilloud
Recent Pat Antiinfect Drug Discov
. Dec 01, 2012.7(3):189-204 Print
Source:PubMed
PMID:
22963258
doi:10.2174/157489112803521968
Retapamulin: an antibacterial with a novel mode of action in an age of emerging resistance to Staphylococcus aureus.
Jeffrey M Weinberg, Stephen K Tyring
J Drugs Dermatol
. Oct, 2010.9(10):1198-204 Print
Source:PubMed
PMID:
20941943
doi:
Purchase and use of antimicrobials in the hospital sector of Vietnam, a lower middle-income country with an emerging pharmaceuticals market.
Vu Quoc Dat, Phan Khanh Toan, H Rogier van Doorn, C Louise Thwaites, Behzad Nadjm
PLoS One
. 2020.15(10):e0240830 Electronic-eCollection
Source:PubMed
PMID:
33079967
doi:10.1371/journal.pone.0240830
Superbugs and Superdrugs: a focus on antibacterials--6th annual SMi conference.
Nafsika Georgopapadakou
Expert Opin Emerg Drugs
. May, 2004.9(1):191-5 Print
Source:PubMed
PMID:
15155144
doi:10.1517/14728214.9.1.191
Combating resistance: application of the emerging science of pharmacokinetics and pharmacodynamics.
Michael R Jacobs
Int J Antimicrob Agents
. Dec, 2007.30 Suppl 2:S122-6 Print-Electronic
Source:PubMed
PMID:
17936592
doi:10.1016/j.ijantimicag.2007.07.036
Allergy to antibacterials: the problem with beta-lactams and sulfonamides.
A Cerny, W Pichler
Pharmacoepidemiol Drug Saf
. Aug, 1998.7 Suppl 1:S23-36 Print
Source:PubMed
PMID:
15073956
doi:10.1002/(sici)1099-1557(199808)7:1+
3.3.co;2-v
Target Product Profile and Development Path for Shigellosis Treatment with Antibacterials.
Samuel L M Arnold
ACS Infect Dis
. 05 14, 2021.7(5):948-958 Print-Electronic
Source:PubMed
PMID:
33689318
doi:10.1021/acsinfecdis.0c00889
Antibacterials as anti-inflammatory agents: dual action agents for oral health.
Prem K Sreenivasan, Abdul Gaffar
Antonie Van Leeuwenhoek
. Mar, 2008.93(3):227-39 Print-Electronic
Source:PubMed
PMID:
17851778
doi:10.1007/s10482-007-9197-8
0
Previous
Next